These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK. Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314 [Abstract] [Full Text] [Related]
9. A new grading system for retinal pigment epithelial tears. Sarraf D, Reddy S, Chiang A, Yu F, Jain A. Retina; 2010 Jun; 30(7):1039-45. PubMed ID: 20458264 [Abstract] [Full Text] [Related]
10. Retinal pigment epithelial tears after single administration of intravitreal bevacizumab for neovascular age-related macular degeneration. Gelisken F, Ziemssen F, Voelker M, Bartz-Schmidt KU, Inhoffen W. Eye (Lond); 2009 Mar; 23(3):694-702. PubMed ID: 18239678 [Abstract] [Full Text] [Related]
11. Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration. Garg S, Brod R, Kim D, Lane RG, Maguire J, Fischer D. Clin Exp Ophthalmol; 2008 Apr; 36(3):252-6. PubMed ID: 18412594 [Abstract] [Full Text] [Related]
12. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ronan SM, Yoganathan P, Chien FY, Corcóstegui IA, Blumenkranz MS, Deramo VA, Elner SG, Fastenberg DA, Johnson MW, López M, Mateo C, Moshfeghi DM, Navarro R, Rosenblatt BJ, Sanislo SR, Saxe SJ, Zacks DN. Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313 [Abstract] [Full Text] [Related]
13. Morphological and functional analysis of the loading regimen with intravitreal ranibizumab in neovascular age-related macular degeneration. Bolz M, Simader C, Ritter M, Ahlers C, Benesch T, Prünte C, Schmidt-Erfurth U. Br J Ophthalmol; 2010 Feb; 94(2):185-9. PubMed ID: 19692384 [Abstract] [Full Text] [Related]
14. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration. Dadgostar H, Ventura AA, Chung JY, Sharma S, Kaiser PK. Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484 [Abstract] [Full Text] [Related]
15. Time course of morphologic effects on different retinal compartments after ranibizumab therapy in age-related macular degeneration. Ahlers C, Golbaz I, Stock G, Fous A, Kolar S, Pruente C, Schmidt-Erfurth U. Ophthalmology; 2008 Aug; 115(8):e39-46. PubMed ID: 18675694 [Abstract] [Full Text] [Related]
16. Tears of the retinal pigment epithelium: an old problem in a new era. Chang LK, Sarraf D. Retina; 2007 Jun; 27(5):523-34. PubMed ID: 17558312 [Abstract] [Full Text] [Related]
19. Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease. Wong LJ, Desai RU, Jain A, Feliciano D, Moshfeghi DM, Sanislo SR, Blumenkranz MS. Retina; 2008 Oct; 28(8):1151-8. PubMed ID: 18685542 [Abstract] [Full Text] [Related]
20. Retinal pigment epithelium tears after intravitreal bevacizumab in pigment epithelium detachment. Weinberger AW, Thiel M, Mohammadi B, Theofylaktopoulos I, Thumann G, Walter P. Am J Ophthalmol; 2007 Aug; 144(2):294-6. PubMed ID: 17659961 [Abstract] [Full Text] [Related] Page: [Next] [New Search]